Packaging | June 09, 2024
Syntegon acquires Telstar
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
This strategic decision will unlock significant value for our scientific and industrial products business
HaystackAnalytics is engaged in the business of developing genomic analysis software
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Subscribe To Our Newsletter & Stay Updated
